BLFS (STOCKS)
BioLife Solutions Inc.
$20.110000
+0.370000 (+1.87%)
Prev close: $19.740000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Roderick de Greef
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $970.83M
- Employees
- 159
- P/E (TTM)
- -64.27
- P/B (TTM)
- 2.56
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $96.21M |
| Benefits Costs and Expenses | $108.30M |
| Cost Of Revenue | $34.10M |
| Costs And Expenses | $78.72M |
| Gross Profit | $62.12M |
| Nonoperating Income/Loss | $4.52M |
| Operating Expenses | $78.72M |
| Research and Development | $7.57M |
| Other Operating Expenses | $71.15M |
| Operating Income/Loss | -$16.60M |
| Income/Loss From Continuing Operations After Tax | -$12.13M |
| Income/Loss From Continuing Operations Before Tax | -$12.08M |
| Income/Loss From Discontinued Operations Net Of Tax | $7.54M |
| Income Tax Expense/Benefit | $49.00K |
| Income Tax Expense/Benefit, Deferred | $65.00K |
| Net Income/Loss | -$4.60M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$4.60M |
| Net Income/Loss Available To Common Stockholders, Basic | -$4.60M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.09 |
| Diluted Earnings Per Share | -$0.10 |
| Basic Average Shares | 47,753,824 |
| Diluted Average Shares | 48,645,084 |
| Assets | $405.88M |
| Current Assets | $136.56M |
| Inventory | $30.16M |
| Other Current Assets | $106.41M |
| Noncurrent Assets | $269.32M |
| Fixed Assets | $14.71M |
| Intangible Assets | $4.26M |
| Other Non-current Assets | $250.35M |
| Liabilities | $34.00M |
| Current Liabilities | $22.98M |
| Accounts Payable | $1.49M |
| Other Current Liabilities | $21.49M |
| Noncurrent Liabilities | $11.02M |
| Long-term Debt | $5.00M |
| Other Non-current Liabilities | $6.02M |
| Equity | $371.89M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $371.89M |
| Liabilities And Equity | $405.88M |
| Net Cash Flow From Operating Activities | $20.12M |
| Net Cash Flow From Operating Activities, Continuing | $20.12M |
| Net Cash Flow From Investing Activities | -$71.54M |
| Net Cash Flow From Investing Activities, Continuing | -$71.54M |
| Net Cash Flow From Financing Activities | -$10.92M |
| Net Cash Flow From Financing Activities, Continuing | -$10.92M |
| Net Cash Flow | -$62.35M |
| Net Cash Flow, Continuing | -$62.35M |
| Comprehensive Income/Loss | -$4.49M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$4.49M |
| Other Comprehensive Income/Loss | $108.00K |